Targeting the pregnane X receptor using microbial metabolite mimicry
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F20%3A73601274" target="_blank" >RIV/61989592:15310/20:73601274 - isvavai.cz</a>
Result on the web
<a href="https://www.embopress.org/doi/full/10.15252/emmm.201911621" target="_blank" >https://www.embopress.org/doi/full/10.15252/emmm.201911621</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.15252/emmm.201911621" target="_blank" >10.15252/emmm.201911621</a>
Alternative languages
Result language
angličtina
Original language name
Targeting the pregnane X receptor using microbial metabolite mimicry
Original language description
The human PXR (pregnane X receptor), a master regulator of drug metabolism, has essential roles in intestinal homeostasis and abrogating inflammation. Existing PXR ligands have substantial off-target toxicity. Based on prior work that established microbial (indole) metabolites as PXR ligands, we proposed microbial metabolite mimicry as a novel strategy for drug discovery that allows exploiting previously unexplored parts of chemical space. Here, we report functionalized indole derivatives as first-in-class non-cytotoxic PXR agonists as a proof of concept for microbial metabolite mimicry. The lead compound, FKK6 (Felix Kopp Kortagere 6), binds directly to PXR protein in solution, induces PXR-specific target gene expression in cells, human organoids, and mice. FKK6 significantly represses pro-inflammatory cytokine production cells and abrogates inflammation in mice expressing the human PXR gene. The development of FKK6 demonstrates for the first time that microbial metabolite mimicry is a viable strategy for drug discovery and opens the door to underexploited regions of chemical space.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30104 - Pharmacology and pharmacy
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
EMBO Molecular Medicine
ISSN
1757-4676
e-ISSN
—
Volume of the periodical
12
Issue of the periodical within the volume
4
Country of publishing house
DE - GERMANY
Number of pages
19
Pages from-to
"e11621-1"-"e11621-19"
UT code for WoS article
000526640800009
EID of the result in the Scopus database
2-s2.0-85081220801